Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Vir Biotechnology, Inc.

NASDAQ: VIR · Life Sciences · 9 alerts · CIK 1706431

Vir Biotechnology, Inc. stories on ALFA USA NewsRead the news →
Share price
$9.58Close, Nov 16
Market cap
$1.64B
Shares outstanding
171.27MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Vir Biotechnology, Inc. filings on SEC EDGAR ↗

8:37 AM ET 8-K
Executive Compensation

Vir Biotechnology Executive Compensation

Vir Biotechnology appointed Suzanne Topalian, M.D., to its Board of Directors and the Science and Technology Committee, effective October 27, 2026. As a non-employee director, she will receive standard cash and equity compensation, including stock options and restricted stock units under the company's 2019 Equity Incentive Plan. The board size was increased from eight to nine members to accommodate the appointment.

Counterparty
Suzanne Topalian, M.D.
8:34 AM ET 8-K
Executive Compensation

Vir Biotechnology Executive Compensation

Vir Biotechnology appointed Aziz Sawaf as Executive Vice President and Chief Financial Officer, effective October 5, 2026. His compensation package includes an annual base salary of $520,000, a $150,000 sign-on bonus, and equity awards consisting of 150,000 stock options and 75,000 restricted stock units.

Counterparty
Aziz Sawaf

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.